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Introduction: Collagen is the main protein responsible for resistance 
to flexibility, and in connective tissue disorders of glucose metabolism 
in the diabetic can produce a superglicolization of specific collagens, 
thus reducing levels of flexibility.
Objective: To verify the effects of regular physical exercise on the flex-
ibility levels of type 2 diabetics.
Method: Characterized as a quasi-experimental study. The sample 
was non-probabilistic; 11 female subjects with type 2 diabetes, with a 
mean age of 66.5 ± 1.6 years, participated in the study. The training 
protocol was composed of resistance and aerobic training, the flexibil-
ity assessment was performed before and after the intervention that 
lasted 6 weeks. To assess flexibility, a Tera Flex 1.8 digital flexometer 
was used by Tera Science. For the comparison of the means of the vari-
ables, a variance analysis was used with repeated measures, and mul-
tiple comparisons using Fisher‘s least significant difference method 
and Wilcoxon‘s nonparametric test. For all tests a significance level was 
adopted p < 0.05.
Results: There was an increase from 87.7 ± 12.5 to 102.4 ± 14.6 
(p = 0.003), in the thoracic joint amplitude of the diabetics evaluated.
Conclusion: The training protocol used in this study showed a sig-
nificant increase in the levels of flexibilities of type 2 diabetics, of this 
sample.
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Introduction: The distal peripheral polyneuropathy (DPP) is one of the 
main Diabetes complications and physical exercise can be an alterna-
tive to minimize the signs and symptoms.
Objective: Assessment of resistance training effects on signs and 
symptoms of DPP on type 2 diabetic patients.
Methods: Randomized controlled trial with 10 diabetic patients (7 
women and 3 men 58.8 ± 3.8 years; 71.9 ± 9.1 kg; 158 ± 5.5 cm; 
15.6 ± 10.6 years of DM2 diagnostic) with DDP diagnosed by the DDP 
diagnostic scale (DDPDS). They were randomized in two groups, the 
control group (n = 4) received education sessions about diabetes, and 
the exercise group (n = 6) besides the education sessions, followed a 
moderate exercise training for upper and lower limbs 3 times a week, 
during 12 weeks. The DDPDS provided the Neuropathy Symptom 
Score (NSS) and the Neuropathy Disability Score (NDS) of each individ-
ual. The tactile sensibility was evaluated with the Semmes–Weinstein 
monofilament (10 g). After the Kolmogorov–Smirnov normality test, 
the pared t test was used for intragroup comparisons. For the inter-
group comparison, the t test was used for independent samples both 
on pre and post intervention phases.
Results: The results showed significant improvements on the NDS, 
on both intragroup comparison of the exercise group (p < 0.01) and 
intergroup comparison on the post-intervention moment. The other 
parameters assessed did not show significant difference.
Conclusion: The resistance training was effective on the improvement 
of the Neuropathy Disability Score of type 2 diabetic patients with dis-
tal diabetic polyneuropathy.
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Introduction: Pregestational diabetes is associated with adverse out-
comes for the mother and the newborn. This may further depend on 
the epoch women were treated, due to changes in standards of care 
and maternal clinical characteristics. Our objective was to study char-
acteristics of pregnant diabetic women across two periods of time.
Methods: We evaluated 220 women, 85 with type 1 diabetes (DM) and 
135 with type 2 DM, attended at a specialized prenatal care. Clinical 
characteristics as weight, body mass index (BMI), preeclampsia, cesar-
ean section and newborn outcomes were evaluated. Epoch of care 
was stratified in two periods: from 2005 until 2010 (period 1) and after 
2010 (period 2). Analyses were performed applying the Student‘s t test 
and the Chi square test in SPSS version18.
Results: Type 1 DM was more frequent in period 1 (56.5% vs. 43.5%), 
but was surpassed by type 2 DM in period 2 (63.0% vs 37.0%) 
(p = 0.005). The Figure presents the number of patients with type 1 
and type 2 diabetes taking prenatal care at each year. Previous mac-
rosomia (8.2% vs. 20.5%, p = 0.011) and previous preeclampsia (PE) 
(9.2% vs 21.3%; p = 0.015), as well as pregestational BMI ≥ 25 kg/m2 
(59.1% vs 78%, p = 0.003) were more frequent in period 2. There was 
Fig. 6 See text for description
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a trend to a lower diagnosis of PE (37.0% vs 24.8%; p = 0.055) in the 
second period. We stratified data of the two periods according to type 
of diabetes: in women with type 2 diabetes, previous PE and macroso-
mia were more frequent and ρfamily history of diabetes, less frequent, 
in the second period. Conversely, women with type 1 diabetes pre-
sented higher pre-pregnancy weight and higher A1c test in the sec-
ond period.
Conclusion: Nowadays, women of reproductive age are frequently 
diagnosed as having type 2 diabetes, in parallel to the escalating rates 
of obesity; even those with type 1 DM presented higher pre-gesta-
tional weight in the second period. The effects of nutritional transition 
are also reflected in women with pre-gestational diabetes (Fig. 1).
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Introduction: In diabetes mellitus, changes in skeletal muscle, asso-
ciated with age muscle mass loss, contribute to a decrease of muscle 
strength, balance and control.
Objective: To investigate the effects of physical training after 
3 months of intervention in the balance of elderly with type 2 diabetes.
Method: Characterized as quase-experimental. Twenty-four elderly 
with type 2 diabetes were enrolled in a supervised physical exercise 
program. Two groups of moderate intensity (n = 11) and high intensity 
(n = 13) were organized. The physical training protocol was composed 
of aerobic and strength training. The strength group was divided into 
moderate intensity of 20–25 repetitions and high intensity of 8–15 
repetitions, both with 1′ interval. The aerobic group, which used the 
treadmill, used the protocol with 10′ in the moderate intensity, scale 
13 on the Subjective Effort Perception, and 5′ for high intensity, in the 
scale 15. For balance evaluation we used the sit and stand test. Multi-
ple comparisons were made using Fisher‘s least significant difference 
method. Nonparametric Kruscal-Wallis test was also performed and a 
significance level of p < 0.05 was used for all tests.
Results: There was an improvement in the balance at moderate inten-
sity (pre 4.9 ± 2.0 versus post 6.2 ± 2.2 p = 0.04) and at high intensity 
(pre 3.7 ± 2.6 vs. post 5.0 ± 2.6 p = 0.03).
Conclusion: The physical training used in this study was effective in 
improving the balance of elderly with type 2 diabetes.
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In the 30-week LixiLan-L trial, LixiLan, a novel titratable fixed-ratio 
combination of insulin glargine (Gla-100) and GLP-1RA lixisenatide, 
showed superior glycemic control over Gla-100 alone, both optimized 
to FPG 80–100 mg/dL (maximum 60 U/day), in patients with T2DM 
inadequately controlled on basal insulin ± ≤ 2 oral drugs. In this post 
hoc analysis, safety and efficacy of LixiLan were evaluated in final dose 
categories of Gla-100 (both groups) and lixisenatide (LixiLan group). 
At week 30 (study end), reductions in HbA1c and proportions of 
responders achieving HbA1c < 7% were similar across dose categories. 
Across all dose levels, LixiLan induced body weight loss or prevented 
weight gain. Incidence of documented symptomatic hypoglycemia 
(SMPG ≤ 70 mg/dL) was numerically higher in patients receiving final 
Gla-100 dose < 30 U vs. those receiving ≥ 30 U. This is also shown by 
final lixisenatide dose level. Incidence of nausea was low in the LixiLan 
group (Table), potentially due to slow increase of lixisenatide compo-
nent in the combination. Efficacy and safety of LixiLan were generally 
consistent across final dose categories of its Gla-100 and lixisenatide 
components and consistent with overall treatment groups. These 
results support clinically based dose titration of a fixed-ratio combi-
nation of insulin glargine and lixisenatide. Study code: NCT02058160. 
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